What is the official website of Intertek Melbourn ?

The official website of Intertek Melbourn is http://www.intertek.com/pharmaceutical/melbourn/.

What is Intertek Melbourn's cybersecurity risk score?

Intertek Melbourn has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Intertek Melbourn experienced?

According to Rankiteo, Intertek Melbourn currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Intertek Melbourn been affected by any supply chain cyber incidents ?

According to Rankiteo, Intertek Melbourn has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Intertek Melbourn have SOC 2 Type 1 certification ?

According to Rankiteo, Intertek Melbourn is not certified under SOC 2 Type 1.

Does Intertek Melbourn have SOC 2 Type 2 certification ?

According to Rankiteo, Intertek Melbourn does not hold a SOC 2 Type 2 certification.

Does Intertek Melbourn comply with GDPR ?

According to Rankiteo, Intertek Melbourn is not listed as GDPR compliant.

Does Intertek Melbourn have PCI DSS certification ?

According to Rankiteo, Intertek Melbourn does not currently maintain PCI DSS compliance.

Does Intertek Melbourn comply with HIPAA ?

According to Rankiteo, Intertek Melbourn is not compliant with HIPAA regulations.

Does Intertek Melbourn have ISO 27001 certification ?

According to Rankiteo,Intertek Melbourn is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Intertek Melbourn operate in ?

Intertek Melbourn operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Intertek Melbourn have ?

Intertek Melbourn employs approximately 105 people worldwide.

Does Intertek Melbourn own any subsidiaries ?

Intertek Melbourn presently has no subsidiaries across any sectors.

How many LinkedIn followers does Intertek Melbourn have ?

Intertek Melbourn's official LinkedIn profile has approximately 3,458 followers.

What is the NAICS classification code for Intertek Melbourn ?

Intertek Melbourn is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Intertek Melbourn have a Crunchbase profile ?

No, Intertek Melbourn does not have a profile on Crunchbase.

Does Intertek Melbourn have a LinkedIn profile ?

Yes, Intertek Melbourn maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/intertek-melbourn.

How many cybersecurity incidents has Intertek Melbourn experienced ?

As of October 19, 2026, Rankiteo reports that Intertek Melbourn has not experienced any cybersecurity incidents.

How many peer or competitor companies does Intertek Melbourn have ?

Intertek Melbourn has an estimated 5,773 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Intertek Melbourn

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

Intertek Melbourn Vendor Cyber Rating & Cyber Score

intertek.com

Add Your Compliance Badge

A leading provider of pharmaceutical analysis and formulation support with 30+ years of experience in inhaled product development and Good Manufacturing Practice (GMP) compliant analytical testing and stability storage services. We have a reputation for providing outstanding and responsive customer service. Previously known as Melbourn Scientific Ltd, the laboratory, based near Cambridge UK, was acquired by Intertek in 2013. We opened a second facility in 2015 and another in 2019 leading to further expansion which has doubled our laboratory footprint. We have specialist skills and experience in analytical testing and formulation for inhaled and intranasal products as well as all other dosage forms for healthcare products. Clients include

Intertek Melbourn

Intertek Melbourn CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Intertek Melbourn Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Intertek Melbourn

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Intertek Melbourn in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Intertek Melbourn in 2026.

Incident Types Intertek Melbourn vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Intertek Melbourn in 2026.

Incident History - Intertek Melbourn (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Intertek Melbourn Subsidiaries

Intertek Melbourn

Pharmaceutical Manufacturing

Website: http://www.intertek.com/pharmaceutical/melbourn/

Company Size: 105

IntertekInternational Trade and Development

Intertek BrazilInternational Trade and Development

Intertek BangladeshInternational Trade and Development

Intertek LatinoaméricaInternational Trade and Development

Intertek Middle EastInternational Trade and Development

Intertek FranceInternational Trade and Development

Intertek EnergyOil and Gas

Professional Service Industries, Inc. (PSI)Civil Engineering

Intertek SpainInternational Trade and Development

Intertek Business AssuranceInternational Trade and Development

Intertek ElectricalAppliances, Electrical, and Electronics Manufacturing

Intertek Agriculture & FoodFood and Beverage Manufacturing

Intertek AssurisConsumer Goods

Intertek SustainabilityInternational Trade and Development

Intertek Greater ChinaInternational Trade and Development

Intertek Softlines and HardlinesRetail

Intertek SwedenInternational Trade and Development

Intertek Transportation TechnologiesMotor Vehicle Manufacturing

Intertek Pharmaceutical ServicesPharmaceutical Manufacturing

Intertek DeutschlandBusiness Consulting and Services

Intertek MineralsMining

Intertek Government and Trade ServicesInternational Trade and Development

Intertek Chemicals & Materials - Laboratory Testing ServicesChemical Manufacturing

Intertek Cosmetics & Consumer HealthcareRetail Health and Personal Care Products

Intertek LintecInternational Trade and Development

Loading…

Intertek Melbourn Similar Companies

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Loading…

NEWS

Intertek Melbourn CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-112112

SUMMARY

An IPv6 FlowSpec validation bypass in the CZ.NIC BIRD Internet Routing Daemon allows an established BGP peer to inject FlowSpec rules matching destinations outside the address space authorized by the unicast-route validation procedure. With validation enabled on the receiving flow6 channel, BIRD fails to reject a destination prefix component with a nonzero offset, contrary to RFC 8956 section 5. It validates a reconstructed prefix with zero-filled skipped bits, although the original FlowSpec component can match a broader set of IPv6 addresses. Given a suitable unicast route from the peer, the rule can pass validation and, where export policy permits, be propagated to downstream peers. Downstream enforcement may cause unauthorized traffic filtering or redirection.

Published

Date2026-10-18

Updated

Date2026-10-18

RISK INFORMATION (Score: )

cvss4

Base Score: 2.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-112111

SUMMARY

The Bootstrap Shortcodes plugin for WordPress before 3.4.6 is vulnerable to stored XSS via the id attribute of the [bs_tcontent] shortcode. The bs_tcontent() shortcode handler in inc/bs_tabs.php emits the id attribute value into an unquoted HTML attribute. esc_attr() is applied, but it does not encode space characters, so a space in the supplied value terminates the attribute and any following text is parsed as additional HTML attributes, including JavaScript event handlers. This allows authenticated attackers with Contributor-level access and above to inject arbitrary web script that executes in the browser of any user who views the page and interacts with the injected element.

Published

Date2026-10-18

Updated

Date2026-10-18

RISK INFORMATION (Score: )

cvss4

Base Score: 5.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-112029

SUMMARY

A vulnerability has been found in diem-project diem up to 5.1.3. This affects an unknown part of the file lib/model/doctrine/PluginDmUser.class.php of the component SHA1 Handler. Such manipulation of the argument salt/password leads to password hash with insufficient computational effort. The attack needs to be performed locally. The attack requires a high level of complexity. It is indicated that the exploitability is difficult. The exploit has been disclosed to the public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-10-18

Updated

Date2026-10-18

RISK INFORMATION (Score: 2.5)

cvss2

Base Score: 1.0

Complexity: HIGH

AV:L/AC:H/Au:S/C:P/I:N/A:N

cvss3

Base Score: 2.5

Complexity: HIGH

CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 1.1

Complexity: HIGH

CVSS:4.0/AV:L/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

REFERENCES

CVE-2026-112028

SUMMARY

A flaw has been found in light0011 cms c774dce31c6df0055568a8d5c53d964d99be199d/f72cf46f601efb2a0618c3814cc2f61380b38930. Affected by this issue is some unknown functionality of the file App/Home/Controller/VoteController.class.php of the component Vote Handler. This manipulation of the argument X-Requested-With causes business logic errors. Remote exploitation of the attack is possible. The exploit has been published and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-10-18

Updated

Date2026-10-18

RISK INFORMATION (Score: 6.5)

cvss2

Base Score: 6.4

Complexity: LOW

AV:N/AC:L/Au:N/C:N/I:P/A:P

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

3.9

REFERENCES

CVE-2026-112027

SUMMARY

A vulnerability was detected in light0011 cms c774dce31c6df0055568a8d5c53d964d99be199d/f72cf46f601efb2a0618c3814cc2f61380b38930. Affected by this vulnerability is the function file_exists of the file Public/Home/js/uploadify/check-exists.php of the component Uploadify. The manipulation of the argument filename results in file and directory information exposure. The attack may be launched remotely. The exploit is now public and may be used. The project was informed of the problem early through an issue report but has not responded yet.

Published

Date2026-10-18

Updated

Date2026-10-18

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Intertek Melbourn Vendor Cyber Rating & Cyber Score

Intertek Melbourn A.I CyberSecurity Scoring

Intertek Melbourn CyberSecurity News & History

Intertek Melbourn Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Intertek Melbourn

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Intertek Melbourn vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Intertek Melbourn (X = Date, Y = Severity)

Intertek Melbourn Subsidiaries

Intertek Melbourn

Intertek Melbourn Similar Companies

Cipla

Sandoz

Novartis

SUN PHARMA

Lonza

Lupin

UCB

Eli Lilly and Company

Zoetis

Intertek Melbourn CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Intertek Melbourn CyberSecurity News & History

Intertek Melbourn Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Intertek Melbourn

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Intertek Melbourn vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Intertek Melbourn (X = Date, Y = Severity)

Intertek Melbourn Subsidiaries

Intertek Melbourn

Intertek Melbourn Similar Companies

Cipla

Sandoz

Novartis

SUN PHARMA

Lonza

Lupin

UCB

Eli Lilly and Company

Zoetis

Intertek Melbourn CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo